Skip to content

Does Statin Initiation Undermine Dietary Behavior?

Does Statin Initiation Undermine Dietary Behavior?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00224159
Enrollment
100
Registered
2005-09-22
Start date
2005-02-28
Completion date
2006-06-30
Last updated
2011-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All English Speaking Adults From the Manhattan VA Clinic Who Have Recently Received Their First Prescription for a Statin

Keywords

Statin therapy, Dietary behavior, Attitudes and beliefs, Self efficacy

Brief summary

The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors

Detailed description

This study explores the impact of initiating statin therapy on subsequent dietary as well as other lifestyle beliefs, attitudes and behaviors. Specific aims: 1. To test whether the initiation of statin therapy increases dietary saturated fat intake among statin naive patients. 2. To determine what role attitudes, beliefs, expectations, motivation, intention and self-efficacy regarding drug or diet therapy may play in observed changes in dietary behavior after starting statin therapy.

Interventions

BEHAVIORALDrug and Dietary behavior

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Weill Medical College of Cornell University
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.

Exclusion criteria

Will include a history of any of the following: 1. Prior CVD (myocardial infarction, angina, angioplasty, stroke, CABG. or arterial bypass surgery) 2. Diabetes patients 3. Psychiatric patients 4. AIDS patients 5. Substance abuse patients 6. Prior cholesterol lowering medication use 7. Inability to complete the interviews

Design outcomes

Primary

MeasureTime frame
How drug or dietary therapy may play a role in dietary behavior.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026